共 50 条
From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research
被引:0
|作者:
Cynthia L. Hsu
Rohit Loomba
机构:
[1] University of California at San Diego,Division of Gastroenterology and Hepatology, Department of Medicine
[2] VA San Diego Healthcare System,Department of Medicine
[3] University of California at San Diego,MASLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine
[4] University of California at San Diego,The Herbert Wertheim School of Public Health and Human Longevity Science
来源:
关键词:
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Non-alcoholic liver disease (NAFLD) is now metabolic dysfunction-associated steatotic liver disease (MASLD), emphasizing the key metabolic factors of obesity, insulin resistance, vascular dysfunction and dyslipidaemia. Here, we discuss impacts on the existing body of clinical and preclinical liver disease research and on research moving forward.
引用
收藏
页码:600 / 602
页数:2
相关论文